Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Jennifer M. Stephens"'
Autor:
Nicholas Streicher, Leslie Amass, Rong Wang, Jennifer M. Stephens, Traci LeMasters, Rutika Raina, Emma Merrill, Farooq H. Sheikh
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 2, Pp 359-368 (2024)
Abstract Introduction Transthyretin amyloidosis (ATTR) is a progressive, heterogeneous rare disease manifesting as ATTR polyneuropathy (ATTR-PN), ATTR cardiomyopathy (ATTR-CM), or a mixed phenotype. Tafamidis meglumine (20 mg po qd) is approved in so
Externí odkaz:
https://doaj.org/article/c978271c36ae4ea18deac4030ba008bf
Autor:
Ashraf El Houfi, Abdulhakeem Al Thaqafi, Thamer H. Alenazi, Fayssal Farahat, Caitlyn T. Solem, Jennifer M. Stephens, Courtney Johnson, Cynthia Macahilig, Wing Yu Tang, Seema Haider
Publikováno v:
Journal of Infection and Public Health, Vol 13, Iss 8, Pp 1126-1133 (2020)
Objectives: To describe opportunities for early switch (ES) from intravenous (IV) to oral (PO) antibiotics and early discharge (ED) of patients hospitalized in the Kingdom of Saudi Arabia (KSA) and the United Arab Emirates (UAE) with methicillin-resi
Externí odkaz:
https://doaj.org/article/81dc91c7ac9448c79c75d98c5cc36ae6
Autor:
Rima Moghnieh, Adel F. Alothman, Abdulhakeem O. Althaqafi, Madonna J. Matar, Thamer H. Alenazi, Fayassal Farahat, Shelby L. Corman, Caitlyn T. Solem, Nirvana Raghubir, Cynthia Macahilig, Jennifer M. Stephens
Publikováno v:
Journal of Infection and Public Health, Vol 10, Iss 6, Pp 849-854 (2017)
The objectives of this retrospective medical chart review study were to document the inpatient incidence, treatment, and clinical outcomes associated with invasive fungal infections (IFI) due to Candida and Aspergillus species, Methicillin-resistant
Externí odkaz:
https://doaj.org/article/c22edb2e75b0413ca14bae16d2f94820
Autor:
Justine Alderfer, Jyoti Aggarwal, Kim Gilchrist, Jose Maria Jimenez Alvir, Joseph Cook, Sang Hee Park, Jennifer M Stephens
Publikováno v:
ClinicoEconomics and Outcomes Research. 14:281-291
Justine Alderfer,1 Jyoti Aggarwal,2 Kim Gilchrist,1 Jose Maria Jimenez Alvir,3 Joseph Cook,4 Sang Hee Park,5 Jennifer M Stephens5 1Medical Affairs, Pfizer Inc., Collegeville, PA, USA; 2Evidence & Access, OPEN Health, Newton, MA, USA; 3Global Product
Publikováno v:
Medical Devices (Auckland, N.Z.)
Introduction Needlestick injuries (NSIs) from a contaminated needle put healthcare workers (HCWs) at risk of becoming infected with a blood-borne virus and suffering serious short- and long-term medical consequences. Hypodermic injections using dispo
Autor:
Abdulhakeem O, Althaqafi, Madonna J, Matar, Rima, Moghnieh, Adel F, Alothman, Thamer H, Alenazi, Fayssal, Farahat, Shelby, Corman, Caitlyn T, Solem, Nirvana, Raghubir, Cynthia, Macahilig, Seema, Haider, Jennifer M, Stephens
Publikováno v:
Infection and Drug Resistance
Objectives The objective of this study is to describe the real-world treatment patterns and burden of suspected or confirmed methicillin-resistant Staphylococcus aureus (MRSA) pneumonia in Saudi Arabia and Lebanon. Methods A retrospective chart revie
Autor:
Bart Heeg, Alan D. Tice, Joseph C. Cappelleri, Jennifer M Stephens, Seema Haider, J. Floris S. Logman, Ben van Hout, Dilip Nathwani
Publikováno v:
Current Medical Research and Opinion. 26:1565-1578
With a growing number of studies and comparators in MRSA skin infections, a unified framework for comparing treatments is needed for health technology assessment (HTA). The objective was to systematically assess the success rates of common antimicrob
Publikováno v:
Annals of Oncology. 17:1072-1082
BACKGROUND Bisphosphonates are recommended to prevent skeletal related events (SREs) in patients with breast cancer and bone metastases (BCBM). However, their clinical and economic profiles vary from one agent to the other. MATERIALS AND METHODS Usin
Autor:
Benjamin L. Laskin, Christopher F. Bell, Jennifer M. Stephens, Chris L. Pashos, Jodie Casagrande, Alberto Redaelli, Marc F. Botteman
Publikováno v:
Expert Review of Anticancer Therapy. 4:85-96
Chronic myelogenous leukemia represents 7-20% of all leukemia cases, with a worldwide incidence projected at less than one to two per 100,000 people. Approximately 85% of patients are diagnosed with chronic-phase chronic myelogenous leukemia and up t
Autor:
Marc F. Botteman, Chris L. Pashos, Jennifer M. Stephens, Alberto Redaelli, Benjamin L. Laskin
Publikováno v:
Expert Review of Anticancer Therapy. 3:311-329
Given the recent advances in the treatment of hematologic malignancies and the many other treatments on the horizon, physicians and payers will be faced with the critical decisions of when to use new treatments in the clinical pathway and how to allo